InterveXion Therapeutics (United States)
- Research works
- 4 ▼ 72% vs 2013–17
- Citations
- 39 8.8 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 60% world 28%
Not ranked overall: InterveXion Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does InterveXion Therapeutics (United States) publish most on?
By volume in 2022–2025: Neurotransmitter Receptor Influence on Behavior, Monoclonal and Polyclonal Antibodies Research and Forensic Toxicology and Drug Analysis.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Neurotransmitter Receptor Influence on Behavior Cellular and Molecular Neuroscience 1 works
- 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
- 3 Forensic Toxicology and Drug Analysis Toxicology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has InterveXion Therapeutics (United States)'s research output changed?
Output in 2018–2022 was 72% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Little Rock
- University of Arkansas for Medical Sciences
- University of Arkansas at Little Rock
- Arkansas Children's Hospital
- University of Arkansas Medical Center
- Central Arkansas Veterans Healthcare System
- University of Arkansas System
- Arkansas Department of Agriculture
- John L. McClellan Memorial Veterans Hospital
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.